agilon health inc (AGL)

In November 2025, Agilon Health received a notice from the NYSE regarding non-compliance with continued listing standards due to its stock price falling below $1.00 for 30 consecutive trading days, and anticipated pursuing a reverse stock split. In May 2026, the stock experienced a substantial rally following a strong Q1 2026 earnings report, beating analyst expectations, and management raised its full-year 2026 guidance. The stock price more than doubled in a single trading session on May 7, 2026, but had experienced a significant decline of 67.14% between May 7, 2025, and May 6, 2026.

Demand for healthcare services, particularly for seniors, exhibits seasonality, with mortality risk and medical care expenditure being highest in the winter and lowest in the summer. Agilon Health's business model is inherently tied to these seasonal variations in healthcare utilization and costs, and the company's Q1 2026 earnings call acknowledged that first-quarter seasonality can produce margin.

Agilon Health, Inc. is a healthcare company focused on transforming primary care for senior patients through its value-based Total Care Model. The company partners with physician groups and health systems, transitioning them from fee-for-service to a model that prioritizes patient outcomes and manages the total cost of care for Medicare Advantage and ACO Model members. Agilon Health provides a platform that includes technology, data analytics, operational support, and capital to facilitate this transition, with the goal of keeping senior patients healthy and reducing hospitalizations. Agilon Health operates within the Healthcare sector, specifically in the Medical Care Facilities industry, and is listed on the NYSE. The company's main product is its partnership model and the agilon Platform, which supports physicians in delivering value-based care through data analytics, care coordination, and patient engagement tools.

Agilon Health has expanded its geographic footprint across the United States, partnering with physician groups in multiple states and operating in over 30 diverse communities. Its headquarters are located in Westerville, Ohio. The company has a presence in states such as California, Texas, Florida, Kentucky, Minnesota, Illinois, and North Carolina, and is focused on further establishing its presence to reach a broader senior population.

Agilon Health's brand reputation was negatively impacted by disappointing financial results in August 2025, the suspension of its 2025 financial guidance, and the resignation of CEO Steven Sell, leading to a sharp decline in the stock price and a securities class action lawsuit. However, the company's strong Q1 2026 earnings beat and raised full-year guidance, along with the appointment of a new CEO in May 2026, could positively impact its reputation.

Agilon Health's ownership is primarily dominated by institutional investors, including Clayton, Dubilier & Rice, LLC, Vanguard Group Inc, and BlackRock, Inc. The company was founded in 2016 by Ronald A. Williams and Veeral Desai, with Ronald A. Williams also serving as Executive Chairman. Institutional investors collectively hold a significant majority of the company's shares, influencing strategic decisions.